Clinical pharmacokinetics of fenofibrate (multiple letters)

Current Medical Research and Opinion

Volumn 19, Issue 2, 2003, Pages 139-140

  Telford, Michael ^a   Elisaf, Moses ^b  

^a Fournier Pharmaceuticals Ltd   (United Kingdom)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

DRUG ABSORPTION; DRUG EFFECT; DRUG EXCRETION; DRUG HYDROLYSIS; DRUG INDICATION; DRUG METABOLISM; DRUG USE; HUMAN; LETTER; MUSCLE DISEASE; PEER REVIEW; PUBLICATION; TREATMENT INDICATION;

ANTILIPEMIC AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; HYPERLIPIDEMIAS; PROCETOFEN;

EID: 0038297506     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079902125001532     Document Type: Letter

References (0)